 New Delhi metallo-β-lactamase (NDM) resistance plasmid has autochthonous circulation in Ecuador.  Klebsiella pneumoniae ST147 harboring NDM-1 gene in an IncA/C plasmid is described for the first time in Quito, Ecuador  NDM circulation in South America has been addressed mainly by Brazil and Colombia.
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Main Text
Antibiotic resistance is a worldwide concern due to the global distribution of multiple plasmids spreading among different bacterial families [1] . Infections with carbapenemase producing bacteria increase mortality and morbidity rates among those infected and therefore impose a high burden over the health sector [2] . New Delhi metallo-β-lactamase (NDM) is one of the most recent class B carbapenemases detected, conferring resistance to all β-lactams antibiotics except aztreonam [3] . Since its first detection in 2008, NDM has been found in several localities in the five continents [1] .
In South America, NDM was reported for the first time in Colombia [4] . We developed a map of the scientific literature reporting NDM in South America by April 30 th , 2017 (Figure 1 and supplementary table) . In Ecuador, NDM gene was recently found in the bacterium Providencia rettgeri [5] and Acinetobacter baumannii (GenBank accession no: MF038874) without confirmation of a plasmid. We report the presence of plasmidborne NDM in a Klebsiella pneumoniae ST147 in a hospitalized patient in Ecuador. and meropenem ≥16 µl/ml, ertapenem 2 µg/ml), cephalosporins (e.g., ceftriaxone ≥64 µg/ml), and quinolones (e.g., ciprofloxacin ≥4 µg/ml), and being sensitive to aztreonam (i.e., 24 mm detected by Kirby Bauer method according to CLSI 2017 [6] ).
We used the following techniques to identify carbapenemase activity: the Modified Hodge Test and Carbapenem Inactivation Method following CLSI 2017 [6] , the synergy with imipenem-EDTA disk method [7] , and the Rapidec Carba NP test following the manufacturer instructions (bioMérieux) ( Table 1) . We identified K. pneumoniae as the variant sequence type (ST) 147 via Multilocus Sequence Typing (MLST), according to Pasteur's scheme (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). We searched the carbapenemase genes blaKPC, blaIMP, blaVIM, and blaNDM using primers described elsewhere [8] , identifying only the NDM-1 carbapenemase gen (GenBank accession no.
MF038875).
We performed a conjugation assay using the broth-mating technique with
an Escherichia coli J53 as the recipient bacterium. We used Sensititre ® with ARGNF plates (Thermo Fisher Scientific, Massachusetts, USA) to determine antibiotic susceptibility at this point (Table 1) . Transconjugants strains were cultivated in
McConkey Agar supplemented with sodium azide (100 mg/L) and meropenem (0.5 mg/L) ( Table 1) ; we confirmed the presence of the blaNDM gene in transconjugants strains using PCR. We further used PCR-based replicon typing (PBRT) to characterize the plasmid from the recipient E. coli J53 [9] , which is part of the incompatibility group A/C (IncA/C).
Once K. pneumoniae was identified, triple antibiotic therapy for the patient was initiated with oral fosfomycin (1 g every 8 h.), and intravenous meropenem (1 g every 8 h.) and colistin methanesulfonate (150 mg every 8 h.). After antibiotic treatment completion (i.e., 21 days), blood cultures and rectal swabs were negative to K. pneumoniae.
Seventy-seven days after his hospitalization the patient was transferred to another hospital to continue the treatment for cryptococcal meningitis and HIV. Due to the novelty of this plasmid-borne resistance pattern for Ecuador, the implementation of control measures was strict and included contact precautions, exclusive nursing personal and vital sign measure equipment, restriction of incoming patients in the area, and rigorous instructions about hand hygiene and isolation methods offered to the people involved in the patient's health care. The patient's spouse and other patients sharing nursing personnel on the same floor (three in total) were examined with rectal swabs to determine Enterobacteriaceae colonization with negative results.
We present the first evidence of autochthonous circulation of NDM-1 harbored by a plasmid of the IncA/C group isolated from a K. pneumoniae ST147 producing a bloodstream infection in an HIV patient from Ecuador. This case should be considered as further evidence of the autochthonous circulation of the NDM-1 plasmid in gramnegative bacilli of Ecuador since the patient has never travelled abroad. Ecuadorian public hospitals should have the ability to detect metallo-β-lactamase enzymes in order to prevent outbreaks. This advice may be followed with the implementation of affordable techniques such as the Carbapenem Inactivation Method, which can consistently detect both serine-and metallo-β-lactamase enzymes [1] . NDM-1 typically confers a broad spectrum of antibiotic resistance compared to other metallo-β-lactamases [3] ; its presence in K. pneumoniae ST147 epidemic strain should be of concern considering the widespread distribution of this bacterium across Ecuador harboring other resistant plasmids [10] . Our literature review showed that local circulation has also been described in other South American countries especially in
Colombia and Brazil where several species of gram-negative bacilli have been found to harbor the NDM gene (supplementary table) . The lack of reports in other South
American countries should be considered with caution due to the variability of surveillance efforts among Latin American countries [11] , and the limited efforts by some of them to publish in international indexed journals (e.g., Ecuador vs. Brazil, see (supplementary table) . We were unable to find records for four South American countries (grey). 
